FDA backs Pfizer booster for 12- to 15-year-oldsJanuary 3, 2022COVID-19 UpdatesVaccinesPulmonologyInfectious DiseasesHealth Policy
Risk for severe COVID-19 and death plummets with Pfizer boosterDecember 9, 2021COVID-19 UpdatesPulmonologyInfectious DiseasesVaccines
FDA authorizes COVID boosters for all U.S. adultsNovember 19, 2021COVID-19 UpdatesInfectious DiseasesPulmonologyVaccines
Mask-wearing cuts new COVID-19 cases by 53%, study saysNovember 19, 2021COVID-19 UpdatesInfectious DiseasesPulmonologyHealth Policy
Long QT and Cardiac Arrest After Symptomatic Improvement of Pulmonary EdemaNovember 10, 2021DiabetesCardiologyPulmonology
Influenza tied to long-term increased risk for Parkinson’s diseaseNovember 2, 2021Infectious DiseasesNeurologyPulmonology
Fluoroquinolones linked to sudden death risk for those on hemodialysisOctober 25, 2021NephrologyInfectious DiseasesPulmonology
Effect of COVID-19 pandemic on respiratory infectious diseases in primary care practiceOctober 12, 2021COVID-19 UpdatesInfectious DiseasesPulmonology